Aptose Total Assets from 2010 to 2026
| APS Stock | CAD 2.26 0.01 0.44% |
Total Assets | First Reported 1997-06-30 | Previous Quarter 5.6 M | Current Value 6.3 M | Quarterly Volatility 28.1 M |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.4 K, Interest Expense of 159.5 K or Selling General Administrative of 6.8 M, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Total Assets |
Evaluating Aptose Biosciences's Total Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptose Biosciences's fundamental strength.
Latest Aptose Biosciences' Total Assets Growth Pattern
Below is the plot of the Total Assets of Aptose Biosciences over the last few years. Total assets refers to the total amount of Aptose Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Aptose Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Aptose Biosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 10.13 M | 10 Years Trend |
|
Total Assets |
| Timeline |
Aptose Total Assets Regression Statistics
| Arithmetic Mean | 29,236,078 | |
| Geometric Mean | 12,548,642 | |
| Coefficient Of Variation | 129.67 | |
| Mean Deviation | 28,628,904 | |
| Median | 11,967,000 | |
| Standard Deviation | 37,910,841 | |
| Sample Variance | 1437.2T | |
| Range | 125.6M | |
| R-Value | 0.27 | |
| Mean Square Error | 1419T | |
| R-Squared | 0.07 | |
| Significance | 0.29 | |
| Slope | 2,047,793 | |
| Total Sum of Squares | 22995.7T |
Aptose Total Assets History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Total Assets, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 11.6 M | 11.1 M |
Other Information on Investing in Aptose Stock
Aptose Biosciences financial ratios help investors to determine whether Aptose Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aptose with respect to the benefits of owning Aptose Biosciences security.